Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

TG Therapeutics

TGTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$25.25

0.170.68%

At Close: -

$25.33

0.080.32%

After Hours: 6:18 PM EDT

15 minutes delayed

Why is it moving?

TG Therapeutics shares are trading higher after the company announced it updated its data presentations to include new five-year data from the ULTIMATE I & II Phase 3 trials evaluating briumvi (ublituximab-xiiy) at the 2024 European Committee for Treatment and Research in Multiple Sclerosis annual meeting.

TG Therapeutics (TGTX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for TG Therapeutics (NASDAQ:TGTX) Stock

TG Therapeutics Stock (NASDAQ: TGTX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, September 18, 2024

Evaluating TG Therapeutics: Insights From 4 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on TG Ther...
Benzinga Newsdesk
What's Going On With TG Therapeutics Stock Wednesday?
Dylan Berman
TG Therapeutics shares are trading higher aft...
Benzinga Newsdesk
TG Therapeutics Presented Updated Data From T...
Benzinga Newsdesk
TG Therapeutics Announced Updated Data Presen...
Benzinga Newsdesk

Monday, September 09, 2024

TG Therapeutics shares are trading higher aft...
Benzinga Newsdesk
What's Going On With ADMA Biologics Stock Monday?
Dylan Berman

Monday, August 19, 2024

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Decoding TG Therapeutics's Options Activity: What's the Big Picture?
Benzinga Insights

Friday, August 16, 2024

A Closer Look at TG Therapeutics's Options Market Dynamics
Benzinga Insights

Wednesday, August 07, 2024

B. Riley Securities Maintains Buy on TG Thera...
Benzinga Newsdesk
Goldman Sachs Maintains Neutral on TG Therape...
Benzinga Newsdesk

Tuesday, August 06, 2024

HC Wainwright & Co. Reiterates Buy on TG Ther...
Benzinga Newsdesk
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Avi Kapoor
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Avi Kapoor
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
TG Therapeutics shares are trading higher aft...
Benzinga Newsdesk
On August 2, 2024 TG Therapeutics Entered In...
Benzinga Newsdesk
TG Therapeutics Raised FY24 Briumvi U.S. Net ...
Benzinga Newsdesk
TG Therapeutics Q2 2024 GAAP EPS $0.04 Beats ...
Benzinga Newsdesk

Friday, July 12, 2024

$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today
Benzinga Insights

Friday, June 21, 2024

Insider Transaction: Sagar Lonial Sells $432K Worth Of TG Therapeutics Shares
Benzinga Insights

Tuesday, June 04, 2024

(TGTX) - Analyzing TG Therapeutics's Short Interest
Benzinga Insights

Friday, May 31, 2024

TG Therapeutics Discloses Presentations For P...
Benzinga Newsdesk

Tuesday, May 14, 2024

Peering Into TG Therapeutics's Recent Short Interest
Benzinga Insights

Thursday, May 02, 2024

HC Wainwright & Co. Maintains Buy on TG Thera...
Benzinga Newsdesk
Ladenburg Thalmann Maintains Buy on TG Therap...
Benzinga Newsdesk

Wednesday, May 01, 2024

Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Watching TG Therapeutics; Hearing M&A Blog Sa...
Benzinga Newsdesk
Market-Moving News for May 1 st
Benzinga Newsdesk
Market-Moving News for May 1st
Benzinga Newsdesk
TG Therapeutics shares are trading higher fol...
Benzinga Newsdesk
TG Therapeutics Updates 2024 Briumvi U.S. Net...
Benzinga Newsdesk
TG Therapeutics Targets Q2 2024 Briumvi U.S. ...
Benzinga Newsdesk
TG Therapeutics Q1 2024 GAAP EPS $(0.07) Miss...
Benzinga Newsdesk

Thursday, April 18, 2024

HC Wainwright & Co. Reiterates Buy on TG Ther...
Benzinga Newsdesk
JP Morgan Reiterates Overweight on TG Therape...
Benzinga Newsdesk
Ladenburg Thalmann Reiterates Buy on TG Thera...
Benzinga Newsdesk
TG Therapeutics Receives National Contract Wi...
Benzinga Newsdesk
TG Therapeutics Announced Two Additional Data...
Benzinga Newsdesk

Wednesday, April 17, 2024

TG Therapeutics Inc Awarded $186,776,520 Cont...
Benzinga Newsdesk

Wednesday, March 13, 2024

(TGTX) - Analyzing TG Therapeutics's Short Interest
Benzinga Insights

Friday, March 08, 2024

TG Therapeutics Announces Schedule Of Data Pr...
Benzinga Newsdesk

Friday, March 01, 2024

HC Wainwright & Co. Reiterates Buy on TG Ther...
Benzinga Newsdesk
TG Therapeutics Announced Data Presentation F...
Benzinga Newsdesk

Thursday, February 29, 2024

Goldman Sachs Maintains Neutral on TG Therape...
Benzinga Newsdesk

Wednesday, February 28, 2024

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved